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Alternative forms of proinsulin mRNAwith differential translational capacities and unknown signif-
icance are expressed in several developing tissues and in the adult pancreas. In the chick embryo
developing heart, we observed low expression of the translationally active transcript of embryonic
proinsulin (Pro1B), and predominant expression of the intron 1-unspliced variant, translationally
inactive. In the embryonic mouse heart, intron 1-unspliced isoform appeared after E12.5. This tight
regulation is required for normal development, since overexpression of Pro1B resulted in abnormal
cardiac morphogenesis in 40% of chick embryos, and was accompanied by changes in gene expres-
sion of Amhc1and Vmhc1.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In mammalian organisms, insulin, secreted mainly by the pan-
creas, acts as an anabolic hormone after birth, maintaining glucose
homeostasis. In the last two decades, other developmental func-
tions of insulin, its precursor proinsulin, and insulin-like peptides
have emerged in vertebrates and invertebrates [1–3]. Moreover,
extrapancreatic proinsulin mRNA expression and alternative
mechanisms of postranscriptional regulation have been reported
[4–8]. We previously characterized insulin gene expression in the
chick embryo during early stages of development, prior to differen-
tiation of the pancreas [3]. Prepancreatic proinsulin remains
unprocessed [9] and its tissue levels are ﬁnely regulated through
the expression of transcript variants (Fig. 1A) that differ in their
translational activity [4,5]. In the prepancreatic embryo, insulin
gene transcription begins 32 nucleotides (nt) 50 upstream of the
pancreatic transcription start site, generating a proinsulin tran-script (Pro1B) with an extension of 32 nt in its 50 untranslated re-
gion (50UTR). This transcript variant has lower translational activity
than the pancreatic isoform (Pro1A) due to the presence of two up-
stream open reading frames [4]. An additional isoform, generated
by the retention of intron 1 in the embryonic Pro1B transcript, is
found in the prepancreatic embryo. The intron 1-containing tran-
script (Pro1B1) has a much longer 50UTR (extra 717-nt) that largely
blocks its translational activity [5]. In the human adult pancreatic
islet, a partially-spliced intron 1 isoform with higher translational
activity has been described [6]. Low levels of the intron 1-retained
isoform have also been reported in the adult mouse pancreas,
although with higher translational activity than the spliced isoform
[8]. These observations indicate that intron 1 retention has differ-
ential effects on proinsulin biosynthesis in different species, and
may respond to distinct functional requirements at the level of
the tissue or organism.
In the chick embryo, tight regulation of proinsulin expression
appears to be essential for normal neural tube formation. Treat-
ment of the embryo during closure of the neural tube with proin-
sulin antisense oligonucleotides increased the proportion of
apoptotic cells in the rostral part of the embryo, indicating that
a physiological function of proinsulin is to regulate cell survival/
death during neurulation [9]. Information is lacking on the
Fig. 1. Expression of proinsulin mRNA transcripts in the developing chick heart. (A)
Schematic organization of the chick insulin gene and proinsulin mRNA transcript
variants. The three exons (E) and two introns (I) of the insulin gene and primers for
standard PCR are indicated. The right primer spans the exon 2–3 splicing junction.
The Pro1B transcript exhibits a 50 extension (clear grey box) as compared with the
pancreatic transcript Pro1A. The Pro1B1 transcript resembles Pro1B but retains
intron 1. (B) RT-PCR for proinsulin mRNA transcripts in chick heart. RT was
performed with RNA from pools of approximately 30–40 (stages 10–14) or 10–15
(stages 16 and 20) hearts. (C) Expression of proinsulin transcripts in the ventricular
and atrial regions of the embryonic chick heart. Quantitative RT-PCR of RNA was
performed from pools of 9 ventricles and 9 atria from stage 12–13 hearts. The levels
of each proinsulin transcript were normalized to GAPDH mRNA levels and the
results expressed as a percentage with respect to the total (Pro1B + Pro1B1). A
control (C) sample lacking cDNA is included in B. The PCR results were replicated
several times with the same pools of hearts and once with another set of embryos.
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proinsulin expression in other developing tissues. The expression
of proinsulin transcripts changes during early cardiogenesis in
chicks; in the precardiac region only the fully-processed mRNA
(Pro1B) is detected, while the intron 1-containing transcript
(Pro1B1) is expressed upon fusion of the heart tubes [5]. The aim
of the present study was to analyze the expression of proinsulin
embryonic transcripts during later stages of cardiac morphogene-
sis in mouse and chick. In addition, we evaluated the pathophysi-
ological consequences of overexpression of translationally active
variants, which increased proinsulin exposure in chick during car-
diac development. We found that mRNA expression of proinsulin2
isoforms in the heart was developmentally regulated in both species.
Moreover, the induction of inappropriately high proinsulin levels
during cardiac morphogenesis in chick, resulted in major cardiac2 We use the term ‘insulin gene’ as used in databases, but ‘proinsulin mRNA’ and
‘proinsulin protein’ to refer to the embryonic expression products.malformations. These alterations were paralleled by abnormal
expression of atrial and ventricular myosine genes.2. Materials and methods
See Supplementary data for full methods.2.1. Embryos and plasmid electroporation
All protocols for animal experiments were in accordance with
EU guidelines for animal research and were approved by the CIB
bioethics committee. Fertilized chicken eggs (Granja Santa Isabel,
Córdoba, Spain) were incubated at 38 C in forced-draft, humidiﬁed
incubators. Mouse embryos (C57BL/6 and CD1) were removed
from the uterus of pregnant females. The day of detection of the
vaginal plug was designated as embryonic day (E) 0.5.
For gain-of-function experiments, stage 3 cultured chick em-
bryos were injected with pCAGs-I-GFP (control), pCAGs-Pro1A-I-
GFP or pCAGs-Pro1B-I-GFP in the region committed to form the
heart and electroporated as described previously [10].2.2. Whole-mount ISH, RNA isolation, PCR and Western blot
All were performed following standard procedures. Speciﬁc
modiﬁcations used and primer sequences are provided in Supple-
mentary data.2.3. Plasmids
pCAGs-Pro1B-I-GFP, pCAGs-Pro1BV5-I-GFP, pCAGs-Pro1A-I-
GFP and pCAGs-Pro1AV5-I-GFP were generated by excising the
corresponding proinsulin cDNA from previously described con-
structs [5] and cloning them into the pCAGs-I-GFP [10].
3. Results
3.1. Regulated expression of proinsulin transcript variants during
cardiogenesis
Two embryonic proinsulin mRNA variants were previously
shown to be dynamically regulated in the initial stages of cardio-
genesis in the chick embryo, prior to pancreatic development [5].
The fully processed, translationally active, transcript was the pre-
dominant variant during speciﬁcation of the cardiac ﬁelds. The per-
centage of intron 1-unspliced, translationally inactive transcript,
subsequently increased, peaking during the formation of the linear
heart tube (stage 10), the ﬁnal stage analyzed in that study [5].
Here, we further characterized proinsulin mRNA expression during
heart morphogenesis, from the heart tube stage through to ventric-
ular and atrial chamber formation (stages 10–20 for chicken and
E8.5–13.5 for mouse, see Supp. Fig. 1). At each stage studied in
the chick embryo, the predominant form of proinsulin mRNA
was the intron 1-unspliced variant (Fig. 1A and B). One of the ﬁrst
morphogenetic events after heart tube formation is the establish-
ment of the anterior–posterior polarity of the tube, exempliﬁed
by the progressive restriction of the expression of the ventricular
and atrial myosine heavy chain genes (Vmhc1 and Amhc1) to the
anterior and posterior portions of the heart tube, respectively
[11]. We thus investigated whether the proinsulin transcript vari-
ants were preferentially distributed in the heart tube. The intron 1-
unspliced variant Pro1B1 represented 90% of the total proinsulin
transcripts in both the atrial (posterior) and ventricular (anterior)
regions, indicating no difference between regions in the expression
of Pro1B1 at this stage (Fig. 1C).
Fig. 2. Expression of proinsulin mRNA transcripts in the developing mouse heart
and pancreas. (A) Schematic organization of the insulin 2 gene, indicating the three
exons (E) and two introns (I) and the primers used for standard PCR. (B) RT-PCR for
proinsulin mRNA transcripts in mouse heart. RT was performed with RNA from
pools of hearts harvested at embryonic days (E) 8.5 (n = 24), E9.5 (n = 28), E10.5
(n = 14), E12.5 (n = 14) and E13.5 (n = 7). The arrow indicates the fully spliced
transcript and the arrowhead indicates the ampliﬁed band corresponding to
unspliced intron 1 isoform. The PCR results were replicated once. (C) RT-PCR for
proinsulin mRNA transcripts in mouse pancreas. RT was performed with RNA from
pools of 4–8 pancreas, except from E15.5–E16.5 stages when 2 pancreas were
pooled. A control (C) sample lacking cDNA is included in B and C. Note that the
intron 1 is 114 nt, slightly longer than the 102 nt reported by Minn et al. (2005) [6],
and we consider the initiation of transcription as mapped by Wentworth et al.
(1986) [24].
Fig. 4. Expression of insulin receptor transcripts in the developing heart. RT-PCR for
insulin receptor (IR) transcripts in embryonic chick (A) and mouse (B) hearts. A
control (C) sample lacking cDNA is included. RT-PCR was performed with RNA from
pools of hearts as described in the legend to Fig. 1 for chick; for mouse embryos,
pools of 20–28 hearts (E8.5–E11.5) or 10–15 hearts (E12.5–E15.5) were used. Note
that the two spliced mRNA variants of the mouse insulin receptor (IRA and IRB,
arrowheads) were expressed at all embryonic stages analyzed in mice, while only
one form of IR (corresponding to the IRA isoform) exists in chicks.
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mental stages in the mouse embryo revealed the presence of a sin-
gle form of proinsulin mRNA from the earliest stage analyzed(E8.5,
heart tube stage), corresponding to the fully spliced mRNA. An
additional proinsulin transcript variant was detected from E12.5
onwards (Fig. 2B). The shortest molecular weight PCR band corre-
sponded to the fully spliced isoform and the largest to the intron 1-
unspliced isoform (all data conﬁrmed by DNA sequencing). By con-
trast, in the developing mouse pancreas, at the level of sensitivity
of semi-quantitative PCR, we only detected expression of the fully
processed proinsulin transcript (Fig. 2C). These results indicate thatFig. 3. Proinsulin translation levels after electroporation of whole chick embryos.
Whole chick embryo lysates were resolved by SDS–PAGE and immunoblotted
sequentially with three antibodies. The embryos had been collected directly from
the incubated egg (in ovo) or after electroporation with plasmids (all were pCAGS-I-
x-GFP) either control (GFP) or embryonic proinsulin-V5 transcripts (Pro1AV5,
Pro1BV5). For this particular experiment, both proinsulin transcripts were fused to
the V5 epitope to facilitate detection of the proinsulin protein. The anti-V5
recognizes the V5 tag linked to proinsulin which is not processed to insulin in the
embryo. Anti-GFP immunoblotting indicates electroporation efﬁciency and anti-
GAPDH was used as a loading control. Note that Pro1BV5-overexpressing embryos
(lysates 1 and 2 from two different embryos) displayed much lower proinsulin
levels than the Pro1AV5-overexpressing embryo lysate, despite their higher
(sample 1) or similar (sample 2) GFP levels. The blot shown is representative of
three experiments.post-transcriptional regulation of heart proinsulin mRNA occurs
during mouse cardiac morphogenesis, although at later develop-
mental stages than in the chick.
We next investigated the potentially deleterious effects of
supraphysiological embryonic proinsulin in cardiogenesis in the
chick embryo model. Before evaluating the embryonic phenotype,
two constructs carrying a V5 tag were electroporated into gastru-
lating chick embryos (stage 3), and were tested for their ability
to translate in vivo. Analysis of whole embryo protein extracts
showed that these constructs gave rise to high (Pro1A) or moderate
(Pro1B) levels of proinsulin (Fig. 3). Note that the molecular weight
of the protein yield produced by the electroporated constructs cor-
responded to that of unprocessed proinsulin, as does the endoge-
nously expressed protein at these embryo stages [9].
3.2. Insulin receptor mRNA is expressed in the developing heart
We next analyzed the expression of insulin receptor (IR) as a
potential mediator of proinsulin signaling. IR expression was de-
tected in the developing heart in chick and mouse embryos at all
ages studied (Fig. 4). One single band was PCR-ampliﬁed in chick,
in agreement with our previous ﬁnding of only one IR isoform (cor-
responding to the IR-A isoform) in this species [12]. This semi-
quantitative approach revealed IR expression at all ages tested, be-
tween stages 10 and 20 (Fig. 4A).
In the embryonic mouse heart, both IR-A and IR-B isoforms
were identiﬁed from E8.5 onwards, with the IR-A form increasing
its expression slightly in the second half of gestation
(Fig. 4B).These ﬁndings suggest that both the chick IR and mouse
IR-A can mediate proinsulin signaling, as the IR-A isoform has been
recently shown to bind proinsulin with high afﬁnity and trigger
intracellular signaling pathways upon autophosphorylation [13].
3.3. Overexpression of proinsulin mRNA induces abnormal cardiac
gene expression and morphogenesis
We previously demonstrated that while some proinsulin signal-
ing is essential during early development, proinsulin overexpres-
sion is deleterious for neural tube development [9]. We thus
analyzed the effect of supra-physiological levels of embryonic pro-
insulin on chick cardiogenesis. The two constructs producing high
(Pro1A) and moderate (Pro1B) proinsulin levels were electropora-
ted into gastrulating chick embryos and morphological evaluation
was performed. Overexpression of Pro1A and Pro1B induced car-
diac malformations in different proportions of up to 61%, while
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(see Supp. Table 1). The malformations observed included cardia
biﬁda, aberrant torsion and a ‘‘globular’’ aspect of the heart tube
(Fig. 5A). Moreover, the severity of cardiac malformation was cor-
related with the translational activity of the transcripts. Whereas
38% of highly proinsulin expressing embryos (Pro1A-electropora-
ted) showed absence of a beating heart formed, all of the moder-
ately proinsulin expressing embryos (Pro1B-electroporated)Fig. 5. Proinsulin overexpression in chick embryos alters anterior–posterior heart tube
images of proinsulin (pCAGs-Proinsulin-I-GFP)-electroporated chick embryos (three exa
GFP)-electroporated embryo. The shape of the heart tube is outlined with yellow dots.
ﬂuorescence images of the same embryos are shown in the corresponding panels on th
isolated panel on the right, double ISH showing normal expression of Vmhc1 (red) and Am
proinsulin (pCAGs-Pro1B-I-GFP)-electroporated chick embryos (two different embryos
dotted line indicates the level of the histological section shown below each panel. In the
expression of Amhc1 in the more central located cells of the heart tube is evident. The s
electroporation. (D) Schematic showing the proposed effect of proinsulin overexpressiondisplayed a beating, although abnormal, heart tube (Supp.
Table 1).
Cardiac gene markers were visualized by in situ hybridization in
control (GFP) and moderately high proinsulin expressing embryos
(Pro1B). Signiﬁcant changes in the expression of the atrial and ven-
tricular chamber genes were observed. In embryos overexpressing
Pro1B, Amhc1 expression was markedly decreased, while a con-
comitant increase in Vmhc1 expression was observed, which inpatterning, resulting in cardiac malformations. (A) Representative light microscopy
mples) exhibiting cardiac malformations, compared with a control GFP (pCAGs-I-
(B) Whole-mount ISH for Amhc1 and Vmhc1 in electroporated chick embryos. GFP
e left. The normal limit of Vmhc1 expression is outlined with yellow dots. On the
hc1 (purple) in a stage 12 embryo. (C) Whole-mount and sections of ISH for Amhc1 of
), compared with a control GFP (pCAGs-I-GFP)-electroporated embryo. The black
se sections, viewed by optical microscopy (20 objective), the discontinuity of the
elected embryos are representative of three to six per group subjected to ISH after
on atrio-ventricular markers in the developing chick heart.
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Pro1A were excluded from the analysis as the severity of the mal-
formations induced confounded analysis. A few embryos were sec-
tioned and examined by optical microscopy (Fig. 5C). In the control
embryos (GFP) there was a gradient in the expression of Amhc1 but
all cells were positive. In contrast, Pro1B electroporated embryos
had dramatically decreased expression and in some cases disconti-
nuity in Amhc1 signal, with the negative cells located at the equa-
tor part of the tube in these horizontal sections (Fig. 5C). This
‘‘butterﬂy’’ image suggests either abnormal or absence of differen-
tiation of a subset of precursors into cardiomyocytes.
Our results thus show that, in the maternally-independent
chick embryo model, supra-physiological proinsulin levels during
cardiogenesis (glucose-independent) alter the dynamic pattern of
gene expression and impair cardiac chamber formation (Fig. 5).
4. Discussion
In vertebrate organisms, insulin expression, regulation, active
form and main function differ between developing and postnatal
stages [for reviews see [1–3]]. The postnatal pancreas abundantly
expresses proinsulin mRNA and secretes mature insulin. The pro-
duction and secretion of insulin is primarily regulated by glucose,
and its main targets are metabolic tissues such as liver, muscle
and fat. By contrast, prior to differentiation of the pancreas, proin-
sulin is the active protein form, and is produced in low abundance
by several extrapancreatic tissues [9]. The expression of embryonic
extrapancreatic proinsulin mRNA is independent of glucose levels,
but depends on the presence of different transcript isoforms, which
mediate distinct protein translation capabilities and tissue- and
time-speciﬁc proinsulin availability [3]. The main aim of the pres-
ent study was to characterize the alternative splicing pattern of
proinsulin mRNA in the developing heart and determine the im-
pact of inappropriately high proinsulin embryo exposure. In the
chick embryo, the predominant proinsulin mRNA isoform detected
during cardiac morphogenesis was the intron 1-unspliced tran-
script. This isoform is translationally inactive, suggesting that inac-
tivation of proinsulin production is required during these stages of
cardiac formation. Indeed, moderate increases in proinsulin levels
induced by overexpression of the Pro1B proinsulin transcript dra-
matically interfered with the cardiac morphogenesis (see later).
Here, we demonstrate that proinsulin production can be abrogated
in the heart by regulating intron 1 processing, rather than com-
pletely switching off insulin gene expression. Previous studies have
demonstrated that the splicing pattern of intron 1 is altered in re-
sponse to growth factor deprivation, increasing proinsulin avail-
ability in the stressed embryo [5]. We thus speculate that
maintenance of proinsulin gene in a transcriptionally active but
translationally inactive state may represent a reversible back-up
mechanism that allows embryonic tissues to adapt to environmen-
tal or developmental changes.
The insulin gene is part of a phylogenetically conserved synteny
formed by the tyrosine hydroxylase (Th), insulin and Igf2 genes. We
previously demonstrated that unusual chimeric RNA transcripts
are generated by Th and insulin genes during embryonic develop-
ment, representing an additional post-transcriptional mechanism
to regulate expression of the two adjacent genes [14]. Although
the function of the chimeric RNA is unknown, alteration of TH lev-
els in the chick embryo induces cardiac defects [10].
In mouse embryos, a proinsulin mRNA intron 1-containing iso-
formwas observed at later stages of cardiac morphogenesis than in
chicks. In contrast tothe effects of intron 1-retention in chicks, the
two alternative proinsulin transcripts generated in mammals by
differential processing of intron 1 have been reported to display
enhanced translational activities [6,8]. Sequence and structural
motifs in the UTR have a major impact on translational regulation[15,16]. Among those 50UTR structural features known to control
translation, long and energetically stable secondary structures im-
pair translation. Comparison of the secondary structure prediction
for the 50UTR of the chick fully-spliced (Pro1B) and intron 1-unsp-
liced (Pro1B1) transcripts (Supp. Fig. 2) revealed a notable change
in free energy (DG = 29 to 256 kcal/mol) due to intron 1 reten-
tion, which includes a very long and stable stem-loop structure;
thus this structural feature may account for the impaired proinsu-
lin translation of the Pro1B1 mRNA. By contrast, mouse intron 1-
retention resulted in a less stable stem-loop structure (change in
free energy from DG = 5.5 to 37 kcal/mol; Supp. Fig. 2), which
appeared not to impair proinsulin translation.
Interestingly, intron 1-containing proinsulin mRNA isoform is
much more abundant in the heart than in the pancreas in embry-
onic stages. Indeed, we detected no expression of the intron 1-con-
taining transcripts in the developing mouse pancreas at any of the
stages analyzed, in agreement with our ﬁndings in the chick [5].
This result is compatible with the very low abundance of intron
1-unspliced transcript described in adult mouse and human pan-
creatic islets [6,8]. Our ﬁndings thus support the functional signif-
icance of RNA processing in the ﬁne tuned proinsulin regulation
required during embryonic development. The differential effects
of intron 1 retention on translational activity in chicks and mice
may reﬂect the distinct proinsulin requirements of each species
during cardiac development.
The additional post-translational regulation speciﬁc to the pan-
creatic islets (i.e., cleavage of proinsulin into mature insulin) fur-
ther differentiates the pancreatic hormone from the growth
factor-like activity of extrapancreatic proinsulin. While an anti-
apoptotic role in neurulating chick embryos has been previously
demonstrated [9], proinsulin may mediate other physiological ef-
fects in the precardiogenic area. Insulin receptor A isoform is ex-
pressed throughout cardiac development in mice and chicks, and
can bind proinsulin with high afﬁnity to predominantly activate
mitogenic pathways [13]. We observed a deleterious effect on
chick cardiogenesis when the physiological decrease in proinsulin
signaling was bypassed by forced expression of the most transla-
tionally active transcript, Pro1A, or the intermediate active tran-
script, Pro1B. These effects were accompanied by signiﬁcant
alterations in the expression of atrial and ventricular chamber
genes. It is unlikely that increased proliferation or inhibition of
apoptosis is implicated (preliminary results not shown). In view
of the observed changes in Amhc1 and Vmhc1, particularly the lack
of expression of Amhc1 in groups of cells (Fig. 5C) when proinsulin
remains high, it is possible that proinsulin downregulation is part
of the heart differentiation or morphogenetic program; further
studies are required to investigate this hypothesis.
A complex network of molecular signals modulates cardiac
morphogenesis and cardiomyocyte differentiation during develop-
ment [17]. Cardiac malformations in mice and humans have been
reported in response to dysregulation of transcription factors and
morphogenetic molecules [18]. As mentioned above, we recently
reported that the catecholaminergic pathway initiated by early
developmental expression of TH plays an important role in regulat-
ing the gene network involved in antero–posterior patterning of
the primitive heart tube [10]. Thus molecules such as proinsulin
and catecholamines, well known for their roles in other contexts
in developed organisms, may play a regulatory role in early
cardiogenesis.
Understanding the impact of high proinsulin levels during
development is clinically relevant, as there is a potential implica-
tion of proinsulin in fetal malformations in infants of obese and
diabetic mothers. Maternal overweight and obesity are associated
with an increased risk of fetal anomalies, including cardiac malfor-
mations [19,20]. They could be additional factors to maternal
hyperglycaemia contributing to that teratogenesis found in type
E. Martínez-Campos et al. / FEBS Letters 587 (2013) 2272–2277 22772 diabetes [21]. Insulin resistance and beta cell dysfunction, typi-
cally associated with increased proinsulin/insulin concentrations
[22,23], are common to obesity and type 2 diabetes, and thus both
proteins are potential teratogens. We wish to place the present re-
sults in the context of the malformations found more frequently in
infants of diabetic and obese mothers and speculate that hyperpro-
insulinemia may contribute to the cardiac malformations in their
infants. Further human studies, performed early in pregnancy,
are required to test this hypothesis.
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